Advancing the global public health agenda for NAFLD: a consensus statement
Open accessThe DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It is a multisystem disease and is considered the hepatic component of metabolic syndrome. Unlike other highly prevalent conditions, NAFLD has received little attention from the global public health community. Health system and public health responses to NAFLD have been weak and fragmented, and, despite its pervasiveness, NAFLD is largely unknown outside hepatology and gastroenterology. There is only a nascent global public health movement addressing NAFLD, and the disease is absent from nearly all national and international strategies and policies for non-communicable diseases, including obesity. In this global Delphi study, a multidisciplinary group of experts developed consensus statements and recommendations, which a larger group of collaborators reviewed over three rounds until consensus was achieved. The resulting consensus statements and recommendations address a broad range of topics — from epidemiology, awareness, care and treatment to public health policies and leadership — that have general relevance for policy-makers, health-care practitioners, civil society groups, research institutions and affected populations. These recommendations should provide a strong foundation for a comprehensive public health response to NAFLD. Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease with a substantial burden worldwide. In this Consensus Statement, a global multidisciplinary group of experts develop consensus statements and recommendations addressing a broad range of topics on NAFLD to raise awareness and spur action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Self-citationChalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Self-citationGlobal Burden of Disease Cancer Collaboration, Fitzmaurice, C., Allen, C., Barber, R. M., Barregard, L., Bhutta, Z. A., Brenner, H., Dicker, D. J., Chimed-Orchir, O., Dandona, R., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5688 · Cited by 6,215
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Self-citationEASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Self-citation2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
Self-citationExpanding consensus in portal hypertension
de Franchis, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.022 · Cited by 3,078
Research works printed but not linked: 2
- Lazarus, J. V. et al. The global non-alcoholic fatty liver disease (NAFLD) preparedness index: are countries ready to tackle the challenge? Int. Liver Congr. 75 (Suppl. 2), 23–26 (2021).
- Grime, M. M. & Wright, G. in Wiley StatsRef: Statistics Reference Online 1–6 (Wiley, 2011).
Cited by
Items 701–800 of 807
Clinical, functional, and nutritional-metabolic characteristics of non-alcoholic fatty liver disease
Znakharenko, E. A., & Gerasimenko, O. N. (2025) · Ateroscleroz · doi:10.52727/2078-256x-2025-21-3-330-339
Pan, Y., Song, F., Liu, X., Zhang, Y., Zhang, J., Chen, S., Song, G., & Ren, L. (2025) · Research Square · doi:10.21203/rs.3.rs-7562588/v1
Chen, Z., Yu, J., Wang, Y., Zhang, D., Hao, J., & Liu, X. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04310-2
“MASLD is closely associated with metabolic dysfunction and is widely recognized as the hepatic manifestation of metabolic syndrome [2].”
Yang, J., Ren, L., Chen, Y., Zhou, Q., Hu, H., Bian, R., Qiu, P., & Lou, D. (2025) · Materials Today Communications · doi:10.1016/j.mtcomm.2025.114033 · Cited by 1
hasannia, F., Keshavarz, S. A., & Shadnoush, M. (2025) · Journal of Nutrition Sciences and Food Technology · doi:10.61882/nsft.20.3.21
Nonlinearity Parameter Imaging Using a Multi-View Joint Inverse Problem Formulation
Avilés, E., Lavarello, R., & Coila, A. (2025) · IEEE International Ultrasonics Symposium · doi:10.1109/ius62464.2025.11201336
“Therefore, a potential application of B/A is diagnosing non-alcoholic fatty liver disease (NAFLD), a metabolic disorder affecting more than a quarter of the global adult population, where conventional transabdominal ultrasound shows limited specificity [3], [4].”
A Robust Machine Learning Framework for Liver Disease Assessment Using Random Forest and SMOTE
Katiyar, K., & Bhat, S. R. (2025) · International Conference on Information, Implementation, and Innovation in Technology (I2ITCON) · doi:10.1109/i2itcon65200.2025.11210565
“Existing diagnostic modalities, including blood tests and imaging, depend significantly on the experience of the clinical management team, which can introduce variations in diagnosis and subsequently delay unguided therapy initiation [23].”
The nonlinear relationship between the hepatic steatosis index and hypertension: NHANES 2017–2020
Zhao, Z., Ma, Y., & Huangfu, W. (2025) · Medicine · doi:10.1097/md.0000000000045755
“[18,19] NAFLD has emerged as a predominant global hepatic disorder, [20] exhibiting strong epidemiological links to obesity, insulin resistance, and cardiometabolic dysfunction.”
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-6979-5
Zia ud din, M., Yuan yuan, X., Ullah Khan, N., & Estay, C. (2024) · Figshare · doi:10.6084/m9.figshare.25052319
Yang, M., Xu, Y., Hu, C., Zhang, S., Kuang, M., & Zou, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19977044
Wang, Y., Tai, Y.-L., Way, G. W., Zeng, J., Zhao, D., Su, L., Jiang, X., Jackson, K. G., Wang, X., Gurley, E. C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21321418
Yuan, X., Li, L., Zhang, Y., Ai, R., Li, D., Dou, Y., Hou, M., Zhao, D., Zhao, S., & Nan, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23650257
Yuan, X., Li, L., Zhang, Y., Ai, R., Li, D., Dou, Y., Hou, M., Zhao, D., Zhao, S., & Nan, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23650251
Cuño-Gómiz, C., de Gregorio, E., Tutusaus, A., Rider, P., Andrés-Sánchez, N., Colell, A., Morales, A., & Marí, M. (2023) · Figshare · doi:10.6084/m9.figshare.24564077
Liu, Z., Huang, H., Xie, J., Hou, L., & Xu, C. (2023) · Figshare · doi:10.6084/m9.figshare.24770264
Zhu, Q., Li, H., Ao, Z., Xu, H., luo, J., Kaurich, C., Yang, R., Zhu, P.-W., Chen, S.-D., Wang, X.-D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20390927
Self-citationYuan, X., Li, L., Zhang, Y., Ai, R., Li, D., Dou, Y., Hou, M., Zhao, D., Zhao, S., & Nan, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23650254
Wang, M., Chang, M., Shen, P., Wei, W., Li, H., & Shen, G. (2024) · Figshare · doi:10.6084/m9.figshare.26635386
Wang, M., Chang, M., Shen, P., Wei, W., Li, H., & Shen, G. (2024) · Figshare · doi:10.6084/m9.figshare.26635380
Mantovani, A., Morieri, M. L., Palmisano, L., Masulli, M., Cossu, E., Baroni, M. G., Bonomo, K., Cimini, F. A., Cavallo, G., Phd, R. B., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26609649
Wang, M., Chang, M., Shen, P., Wei, W., Li, H., & Shen, G. (2024) · Figshare · doi:10.6084/m9.figshare.26635383
Santos, C. M. D. L., Silva, L. D., & Bering, T. (2021) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Bertran Ramos, L. (2023) · Rovira & Virgili repository
Al-Awadi, A. (2023) · Nottingham ePrints (University of Nottingham)
Waqar, A., Anum, A., Jamil, A., Jamil, M. S., & Shabbir, B. (2025) · Annals of King Edward Medical University · doi:10.21649/akemu.v31i4.5899
Sexual Dimorphism in Hepatocellular Carcinoma Progression via ERα-Gα12 Signaling
Tak, J., & Kim, S. G. (2026) · Springer eBooks · doi:10.1007/978-981-95-2070-1_3
Self-citationKAYA, K. L. (2025) · Hasan Kalyoncu University Institutional Repository (Hasan Kalyoncu University)
Abdulkhalik, E., Ibrahim, N., Sidhom, S., Qurashi, H. A., Alghashmari, K., Alotaibi, M., Alqurashi, A. M. A., Alzahrani, M., Alqahtani, S., Alshalan, A., et al. (2026) · Saudi Medical Journal · doi:10.15537/smj.2026.47.1.20250454
“The MASH was found in approximately 20% of MASLD, which may have progressive course from advanced fibrosis to cirrhosis or even hepatocellular carcinoma [1].”
Self-citationKhinji, A. A., Malouche, D., Al-Thani, N., Mustafa, A., Abdulmajeed, J., & Al‐Kuwari, M. G. (2026) · Research Square · doi:10.21203/rs.3.rs-8594404/v1
Bertran, L., Rusu, E. C., Auguet, T., & Richart, C. (2026) · Journal of Laboratory Medicine · doi:10.1515/labmed-2025-0262
Goedeke, S. M. (2024) · Tuwhera (Auckland University of Technology)
Apilan, A. G. (2025) · TSpace (University of Toronto)
Zheng, X., Zhang, Z., Jiao, X., Mu, M., Liu, A. Y., Huang, Y., Wu, W., Liao, C., Jiang, Y., Liang, W., et al. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109721
Tsutsumi, T., Kawaguchi, T., & Fujii, H. (2026) · Journal of Gastroenterology · doi:10.1007/s00535-026-02384-7
Self-citationErnsting, J. V., Tran, A., Beheshtian, A., Nguyen, V., Gannavarapu, B., & Garcia, R. T. (2026) · Pediatric Gastroenterology Hepatology & Nutrition · doi:10.5223/pghn.2026.29.2.141
Kyhl, L. K., Nordestgaard, B. G., Tybjærg‐Hansen, A., Pham, M. H. C., Kühl, J. T., Kofoed, K. F., & Nielsen, S. P. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.106834
Fuel toxicity-associated spectrum (FTAS): a unifying nomenclature for metabolic disorders
Sureshkumar, P. (2026) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-026-00282-8
“The recent paradigm-shifting consensus to rename NAFLD as Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) represents a pivotal step toward a more accurate, mechanistic, and inclusive nomenclature [6–9].”
Abdou, H. A., & Omar, S. A. (2026) · ASIDE Gastroenterology · doi:10.71079/aside.gi.031826446
“[20, 21].”
Wang, Y. S., Li, Y., Zhang, M., Yang, L., Wang, M., Zhou, X., Wang, W., Shi, J., Li, Y., Zhang, X., et al. (2026) · International Journal of Surgery · doi:10.1097/js9.0000000000005129 · Cited by 1
“Therefore, implementing stricter weight management and other lifestyle changes (like blood sugar control measures) worldwide is crucial to alleviating the current and future burden of liver cancer, especially NASH-associated liver cancer [ 42 , 43 ] .”
Dissociation Between Hepatic Steatosis and Paraspinal Myosteatosis on Quantitative MRI
Dölek, B. A., Alcın, E. S., & Alcin, B. (2026) · Metabolic Syndrome and Related Disorders · doi:10.1177/15578518261436372
Lu, X., Wang, X., Liu, D., Zhang, Z., Zhang, Y., Zhang, T., Lü, D., Kuang, S., Lai, C., Piao, F., et al. (2026) · PLOS Digital Health · doi:10.1371/journal.pdig.0001317
“The global prevalence of metabolic-associated fatty liver disease (MAFLD) continues to rise, exerting a substantial impact on cardiovascular health through its strong association with multiple cardiometabolic disorders [1,2].”
Ohanisyan, E. V., Skrypnyk, I. M., Maslova, G. S., & Pilat, I. O. (2026) · Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії · doi:10.31718/2077-1096.26.1.68
Self-citationUnrevealing the Role of Flavonoids in Mitigation of Non-Alcoholic Fatty Liver Disease
Maity, A., Firdous, S. M., Pathak, D., & Paria, B. (2026) · Medicinal Chemistry Research · doi:10.1007/s00044-026-03564-z
Chen, H., Li, Z., Ji, M., Wang, X., Chen, B., Guan, Q., Wu, M., & Lu, L. (2026) · PubMed Central · doi:10.12122/j.issn.1673-4254.2026.04.06
Wu, Y., Wang, J., Xing, Y., Kang, M., Yuan, X., & Shen, Y. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-04844-z
“Consequently, the escalating incidence and severe clinical ramifications underscore the urgent necessity for prioritizing research into the management and risk stratification of this condition [7].”
Metabolic dysfunctionassociated steatotic liver disease in diabetes
Rzayeva, R. A., & Musayeva, N. E. (2026) · https //www saqlamliq · doi:10.58495/10.2001/journal.2026/25
Gutiérrez-Castillo, A., Gutiérrez-Monterrubio, R., Domínguez-Cardoso, P. F., Cayo, A., Mendoza-Ibáñez, A. K., Rosales-Padrón, A., Narváez-Chávez, S., García-Alanis, M., Rubio-Acosta, L., Méndez‐Sánchez, N., et al. (2026) · Medicina · doi:10.3390/medicina62050926
“In response, international initiatives have sought to position MASLD as a public health priority through the development of comprehensive, multidisciplinary strategies and its integration into national NCD agendas [43].”
Leszczynska, A., Kaufmann, B., Sung, H., Stoess, C., Reca, A., Kim, A. D., Choi, Y., Tran, C., Kim, S. E., Povero, D., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-40490-x
Self-citationPan, Y., Song, F., Liu, X., (8098), Y. Z., Zhang, J., Song, G., & Ren, L. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-04986-0 · Cited by 1
“MASLD encompasses a disease spectrum ranging from hepatic steatosis to metabolic dysfunction-associated steatohepatitis (MASH), which can progress to fibrosis, cirrhosis and ultimately, hepatocellular carcinoma (HCC) [4].”
Li, S. B., Yang, X., Jiang, Y., Zhang, L., Zhang, Q., & Li, Z. (2026) · Ultrasound International Open · doi:10.1055/a-2879-4395
Mandal, A., Chatterjee, A., Ganguly, D., Mondal, B., Basu, A., & Basu, P. (2026) · Nutrition and Diabetes · doi:10.1038/s41387-026-00440-y
“In India, it ranges from 28-53% among the urban population, suggesting a higher disease burden [4, 5].”
Disha, P., Harikrishnan, R., Tavse, S., & Srideviponmalar, P. (2026) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2026.100808 · Cited by 1
Martinez, M. B., Filomeni, G., & Rizza, S. (2026) · STAR Protocols · doi:10.1016/j.xpro.2026.104639
Zhou, M., Deng, Y., Huang, Y., Yu, C., Chen, X., Yang, Q., Liao, Y., Wang, S., Zhang, P., 陈爱兰, et al. (2026) · Nutrition & Metabolism · doi:10.1186/s12986-026-01145-w
“The disease progression can lead to cirrhosis, hepatocellular carcinoma (HCC), and liver-related mortality, posing substantial public health and economic challenges [3].”
Yan, W., Wang, L., Yang, X., & Zhang, Y. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1877424
Khalil, I., Al-Badri, S. G., Hossain, M. S., Din, A. U., Ima, M. J., Rahman, M. T., Akter, M. M., Halder, L., Joy, A. D., Promi, S. A., et al. (2026) · Medicine · doi:10.1097/md.0000000000049493
“[15,16] Mortality attributable to NAFLD has garnered increasing attention as the disease progresses to advanced stages.”
Sheng, W., Zhang, Z., Song, D., Shen, Y., Zhang, X., Xiang, Y., Lu, L., Li, C., Liu, C., Ji, G., et al. (2026) · Liver International · doi:10.1111/liv.70755
Self-citationMELHAC Improves Glucose and Lipid Metabolism in HFD + Alloxan-Induced Mice
Wang, Z. P., Yang, Y., Geng, Z., Hu, S., Jin, W., Tang, H., Zou, J., Liu, C. J., & Zhu, Y. (2026) · Nutrients · doi:10.3390/nu18132145
“Disorders of glucose and lipid metabolism, including obesity, type 2 diabetes mellitus (T2DM), dyslipidemia, and non-alcoholic fatty liver disease (NAFLD), have become major global health challenges [1,2].”
Self-citationShelukar, S., Venkatesh, A., McDermott, B., Gervase, J., Winte, M. F., Loh, R., & Halegoua-De Marzio, M. (2026) · The Medicine Forum
Wan, K. S., Chan, W., Yusoff, M. F. M., Mustapha, F. I., Noor, N. M., & Ahmad, N. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-60963-3
Self-citationLuyao, X., Li, Q., Lu, C., Zheng, M., Guo, W., Chen, Y., Dai, J., Deng, Y., Zhang, N., Yang, K., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1767119
“…steatosis (referred to as non-alcoholic fatty liver, NAFL) to steatosis accompanied by in fl ammation and ballooning hepatocyte cell death termed non-alcoholic steatohepatitis (NASH), which potentially progresses to hepatic fi brosis, cirrhosis, and even hepatocellular carcinoma (HCC) (1, 3, 4).”
Pîrșcoveanu, D. F. V., Pluta, I. D., Dîrnu, R., Vlădulescu, C., Trașcă, D.-M., Văruț, R. M., Kamal, A. M., Stoica, M., Pura, G., Popa, R., et al. (2026) · Molecules · doi:10.3390/molecules31142415
“…diet and intestinal microbiota play central roles in metabolic regulation, dietary components capable of modulating microbial fermentation, short-chain fatty acid (SCFA) production, intestinal barrier function, and lipid handling have become increasingly relevant in metabolic research [25–30].”
Bandaranaike, R., Kewish, M. F., & Tarwater, S. (2026) · ASIDE Gastroenterology · doi:10.71079/aside.gi.071126795
Liu, X., & Zhou, C. (2026) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/cjgh/4834539
Julián, M. T., Rubio, M. Á., Escalada, J., & Alonso, N. (2026) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2026.501846
Suyono, Mundir, & Suhardi, A. (2026) · Mumtaz. · doi:10.69552/mumtaz.v6i1.3246
Microbiota and lipid mediators: from molecular crosstalk to therapeutic opportunities
Gökcen, B. B., Atabılen, B., Güneş, B. D., Dazıroğlu, M. E. Ç., Özer, Ş. D., Biten, A. A., Pagano, E., Nanì, M. F., Romano, B., Ağagündüz, D., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1836931
“It is recognized as a multisystem disorder and represents the MetS manifestation related to the liver (Lazarus et al., 2022).”
Huang, H.-T., Hewitt, M., Li, W., Temperley, L., Sattar, N. A., & Alazawi, W. (2026) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2026.101808
Матій, В. В., & Рішко, М. В. (2024) · Проблеми клінічної педіатрії · doi:10.24144/1998-6475.2024.2.(64).61-68
Liang, B., Shi, H., Tie, X., Zeng, Q., & Long, K. (2026) · Medicine · doi:10.1097/md.0000000000049944
“[23,29] Countries should develop national NAFLD strategies, embed surveillance within essential public-health services, [30] and adopt age-targeted measures – integrated management and regular screening for high-risk adults ≥50 years, alongside lifestyle promotion to reduce future burden in younger…”
Zhu, S., Yang, F., Lu, H., Jiang, J., & He, W. Q. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1843719
Non-Alcoholic Fatty Liver Disease, Diet and Contributing Factors: A Narrative Literature Review
Joseph, R., Tharpe, A. A., & Walker, S. A. (2026) · Wisdom & Compassion The LUSON Journal · doi:10.70623/jfjm4531
Luangjaru, S., Vipatakul, N., Malikhao, S., & Rattanawarang, W. (2026) · Research Medical Journal · doi:10.33165/rmj.2027.e277606
Cen, Y., & Xuan, Y. (2026) · Scientific Reports · doi:10.1038/s41598-026-65063-w
Shen, X., Yan, C., & Gong, X. (2026) · Research Square · doi:10.21203/rs.3.rs-10175659/v1
Kupriyanova, I. N., Sakhno, A. V., & Sudarikova, K. V. (2026) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-240-8-32-40
Toxic crossroads: environmental pesticides and their endocrine footprints in global metabolic health
Onikanni, S. A., Murucci, M. D., da Costa, T. G., Amos, O. E., Ajayi, O. D., Dao, T., Ajiboye, B. O., Adewole, E., Piperni, S. G., & Miranda‐Alves, L. (2026) · Journal of Molecular Endocrinology · doi:10.1530/jme-25-0183
Du, Y., Qi, L., Shi, Y., Huang, X., Shi, X., Liu, M., Fang, Y., & Hu, X. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1912000
Qiu, T., Cao, J., Yang, X., Luo, Y., Wang, H., & Ling, W. (2026) · Journal of Biophotonics · doi:10.1002/jbio.70344
MASLD pri asimptomatski odrasli populaciji
Perko, T. (2026) · Repository of the University of Primorsk (University of Primorska)
Santos, A. R. M., da Cruz, A. G., de Camargo, F. N., dos SANTOS, J. D. M., Model, J. F. A., Silva, J. F. T., Matos, S. L., Araujo, L. C. C., & Camporez, J. P. (2026) · Cells · doi:10.3390/cells15171544
“It develops from metabolic dysfunction-associated steatotic liver disease (MASLD), which affects approximately one-third of the adult population worldwide and is projected to increase substantially over the coming decades [1–4].”
Nam, S. W. (2026) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2026.00482
Mahadule, D., Gangwar, A., Purohit, K. J., Sarmah, N. R., Yadav, N., Singh, H., Shelke, A., Navale, A. M., & Wakchaure, R. S. (2026) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-026-00719-7
“This is mainly due to limited information on their bioavailability, pharmacokinetics, appropriate dosage, and long-term safety [182].”
Identifying MASLD Patients with MASH or Significant Fibrosis: The Role of Lower ALT Thresholds
Ma, Y., Yang, H., Zhao, Y., Han, P., Jin, Y., Lili, Z. H. A. O., Liu, J., & Li, J. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15187212
“Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a growing global health burden, encompassing a disease spectrum that ranges from simple steatosis to metabolic steatohepatitis (MASH), cirrhosis, and hepatocellular carcinoma (HCC) [1–4].”
Zhao, R., Lü, J., Xiong, F., Wang, Y., Zhang, C., Wei, G., Zhang, Q., & Yang, J. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71362
He, M., Liu, A., & Liu, Y. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6c03179
MASLD beyond the liver: decoding the gut–genetic–metabolic nexus
Attieh, P., Nassif, M., Maghzal, M., Bedran, A., Kassas, J., Othman, M., Sahyoun, F., Harb, F., Azar, S. T., & Ghadieh, H. E. (2026) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2026.1824548
Dynamic Crosstalk Between TREM2+ Macrophages and the MASLD Hepatic Microenvironment
Li, X., Yu, C., Mao, A., Peng, Y., Yiyang, H., & Zhao, Y. (2026) · Biomedicines · doi:10.3390/biomedicines14102167
“…metabolic stress promotes hepatocyte injury and death, which in turn reshapes the hepatic immune and stromal microenvironment and drives progression from steatosis to metabolic dysfunction-associated steatohepatitis (MASH), hepatic fibrosis (HF), cirrhosis, and hepatocellular carcinoma(HCC) [4,5].”
Du, F., Zhao, S., Mi, S., Shi, Y., Hou, M., Zhang, Y., Shi, C., Cai, W., 吴卫东, & Cao, Z. (2026) · Environmental Research · doi:10.1016/j.envres.2026.125766
AI-Based CT Liver Segmentation and Fatty Liver Measurement
Lee, M.-C., Lu, C.-L., Shiue, Y.-L., Su, C.-Y., Chou, C.-P., & Pan, C.-T. (2026) · IEEE International Instrumentation and Measurement Technology Conference · doi:10.1109/i2mtc66907.2026.11694569
“Current diagnostic tools include liver biopsy, ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI) [2–4].”
Self-citationMetALD in Clinical Practice: Diagnosis, Non-Invasive Risk Stratification, and Management
Krzewiński, H., Wątroba, O., & Koza, J. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15197540
“Evolution of Nomenclature: From NAFLD/ALD to MASLD and MetALD For decades, fatty liver disease was classified according to a rigid either/or split between Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol-Related Liver Disease (ALD) [1–3].”
LEAN MASLD: METABOLIC HETEROGENEITY AND IMPLICATIONS FOR DISEASE PROGRESSION
Popielska, J., Zima, S., Stawarski, B., Jędral, A., Miścior, A., Kucharczyk, J., Gajczak, M., Łukasiewicz, K., Kuzdak, K., & Jabłońska, K. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6122
Dai, X., Ye, M., Li, X., Chen, Y., Fu, H., Xu, L., Wang, L., Shen, Z., & Zhu, Y. (2026) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-026-06838-y
Prevalence of metabolic syndrome in Nepal: A systematic review of all published studies
Rana, R., Kamath, S. U., Shastri, B. A., Umakanth, S., Maiya, G. A., Kamath, U., Raghavendra Rao, S., & Adhikari, P. (2025) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v96i4.16751
Zheng, M., Zou, M., Chen, H., Gong, L., Wang, N., & Su, Z. (2026) · Medicine · doi:10.1097/md.0000000000050989
“[22] Public awareness campaigns promoting healthy life-styles, including balanced diets and regular physical activity, are essential.”
Self-citationNon-Alcoholic Fatty Liver Disease as a Systemic Metabolic Disorder
Aleksandra, M. (2026) · Journal of chemical health risks
Zhu, Y., Ma, J., 王丹虹, Cui, M., Peng, J., Lu, X., Pei, X., Wang, Y., Lv, J., Yan, Y., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00606-1
“The escalating global prevalence of MASLD amidst the obesity pandemic underscores the urgent need for novel therapeutic strategies [34, 35].”
Wei, X., Lin, L., Wang, X., Du, H., Zhang, M., Tang, K., Gao, H., Xie, X., Gao, J., Wang, X., et al. (2026) · Advanced Science · doi:10.1002/advs.78372
“During MASLD progression, hepatic fatty acid accumulation, IR, and chronic inflammation are interdependent pathological processes that mutually reinforce one another, establishing a self-perpetuating cycle that drives disease advancement [ 35–37 ].”
Self-citation
Metadata
- Authors
- Lazarus, J. V., Mark, H. E., Anstee, Q. M., Arab, J. P., Batterham, R. L., Castera, L., Cortez-Pinto, H., Crespo, J., Cusi, K., Dirac, M. A., Francque, S., George, J., Hagström, H., Huang, T. T.-K., Ismail, M. H., Kautz, A., Sarin, S. K., Loomba, R., Miller, V., Newsome, P. N., Ninburg, M., Ocama, P., Ratziu, V., Rinella, M., Romero, D., Romero-Gómez, M., Schattenberg, J. M., Tsochatzis, E. A., Valenti, L., Wong, V. W.-S., Yilmaz, Y., Younossi, Z. M., Zelber-Sagi, S., the NAFLD Consensus Consortium, Åberg, F., Adams, L., Khatry, M. S. A., Naamani, K. A., Murillo, O. A., Allen, A. M., Alnaser, F., Alqahtani, S. A., Alswat, K., Alvaro, D., Andrade, R. J., Arrese, M., Awuku, Y. A., Ayesha, M., Baatarkhuu, O., Bakieva, S., Basu, R., Bataller, R., Bedri, S., Bosi, E., Bourliere, M., Bruha, R., Bugianesi, E., Burra, P., Buti, M., Byrne, C. D., Calleja, J. L., Carrieri, P., Carter, F., Fernandez, M. I. C., Castillo-Lopez, G., Castro-Narro, G. E., Chan, H. L. Y., Chan, W.-K., Chang, Y., Colombo, M., Coppell, K. J., Corey, K., Craxi, A., Cryer, D., Dassanayake, A., Martins, A. D. A. S., de Ledinghen, V., DelPrato, S., Demaio, A., Desalegn, H., Dillon, J., Duseja, A., Dorairaj, P., Ekstedt, M., El Kassas, M., Elsanousi, O. M., Esmat, G., Fan, J.-G., Farpour-Lambert, N., Flisiak, R., Fouad, Y., Fuchs, M., Gani, R. A., Gerber, L., Ghazinyan, H., Gheorghe, L., Goh, G. B.-B., Grønbæk, H., Gulnara, A., Hamid, S., Hebditch, V., Hickman, I. J., Hocking, S. L., Hunyady, B., Idilman, R., Isakov, V. A., Jamal, M. H., Jepsen, P., Iskandar, N. J., Song, M. J., Sudhamshu, K. C., Kakizaki, S., Kalamitsis, G., Kanwal, F., Kao, J.-H., Kaplan, L., Kawaguchi, T., Khader, Y., Kim, S. U., Kodjoh, N., Koek, G., Koike, K., Komas, N. P., Korenjak, M., Kugelmas, M., Labidi, A., Lange, N. F., Lavine, J. E., Lazo, M., Lee, N., Lesmana, C. R. A., Liu, C.-J., Long, M. T., Lopez-Jaramillo, P., Malekzadeh, R., Mahtab, M. A., Marchesini, G., Marinho, R., Vázquez, S. E. M., Mateva, L., Nlombi, C. M., Melin, P., Mikolasevic, I., Milovanovic, T., Musso, C., Nakajima, A., Nava, E., Nersesov, A. V., Nikolova, D., Norris, S., Novak, K., Oben, J., Ong, J. P., Onyekwere, C., Papatheodoridis, G., Paruk, I., Patel, K., Macedo, M. P., Penha-Gonçalves, C., Figueroa, M. P., Hofmann, W. P., Petta, S., de Oliveira, C. P. M. S., Puri, P., Pan, C. Q., Rac, M., Ralston, J., Ramji, A., Razavi, H., Alvares-da-Silva, M. R., Roberts, S., Roden, M., Rose, T., Rouabhia, S., Rovere-Querini, P., Rowe, I. A., Sadirova, S., Salupere, R., Saparbu, T., Sayegh, R., Sebastiani, G., Seki, Y., Selmo, J., Serme, A. K., Shaw, J. E., Shenoy, T., Sheron, N., Shibolet, O., Silva, M., Skrypnyk, I., Socha, P., Soriano, J., Spearman, C. W., Sridharan, K., Suárez, J. J., Sheriff, D. S., Sung, K.-C., Swain, M., Tacke, F., Taheri, S., Tan, S.-S., Tapper, E. B., Yki-Järvinen, H., Thiele, M., Shawa, I. T., Tolmane, I., Torres, E. A., Trauner, M., Treeprasertsuk, S., Turcanu, A., Valantinas, J., Vesterhus, M., Waked, I., Wild, S. H., Willemse, J., Wong, R. J., Xanthakos, S., Young, D. Y., Yu, M.-L., Zheng, K. I., Zeybel, M., & Zheng, M.-H.
- Affiliations
- Barcelona Institute for Global Health (ES)
- European Association for the Study of the Liver (CH)
- NIHR Newcastle Biomedical Research Centre (GB)
- Pontificia Universidad Católica de Chile (CL)
- University College London Hospitals NHS Foundation Trust (GB)
- Marqués de Valdecilla University Hospital (ES)
- Veterans Health Administration (US)
- University of Washington (US)
- University of Antwerp (BE)
- The University of Sydney (AU)
- Karolinska Institutet (SE)
- City University of New York (US)
- King Fahd Hospital of the University (SA)
- Institute of Liver and Biliary Sciences (IN)
- University of California San Diego (US)
- University of California, Berkeley (US)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Makerere University (UG)
- Université Paris Cité (FR)
- Northwestern University (US)
- The Graduate Center, CUNY (US)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- The Royal Free Hospital (GB)
- University of Milan (IT)
- Chinese University of Hong Kong (HK)
- Marmara University (TR)
- Inova Health System (US)
- University of Helsinki (FI)
- The University of Western Australia (AU)
- Mayo Clinic (US)
- Johns Hopkins University (US)
- King Saud University (SA)
- Sapienza University of Rome (IT)
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
- University of Health and Allied Sciences (GH)
- University of KwaZulu-Natal (ZA)
- Mongolian National University of Medical Sciences (MN)
- Ministry of Health of the Republic of Uzbekistan (UZ)
- University of Virginia (US)
- University of Pittsburgh (US)
- Ahfad University for Women (SD)
- Vita-Salute San Raffaele University (IT)
- University of Turin (IT)
- University of Padua (IT)
- University of Southampton (GB)
- Inserm (FR)
- University of the West Indies (BS)
- Universidad de Buenos Aires (AR)
- Union Hospital (HK)
- University of Malaya (MY)
- Kangbuk Samsung Hospital (KR)
- IRCCS Ospedale San Raffaele (IT)
- University of Otago (NZ)
- Harvard University (US)
- University of Kelaniya (LK)
- University of Pisa (IT)
- St. Paul's Hospital Millennium Medical College (ET)
- University of Dundee (GB)
- Post Graduate Institute of Medical Education and Research (IN)
- World Heart Federation (CH)
- Linköping University (SE)
- National Ribat University (SD)
- Cairo University hospitals (EG)
- Shanghai Jiao Tong University (CN)
- Medical University of Białystok (PL)
- Minia University (EG)
- Virginia Commonwealth University (US)
- University of Indonesia (ID)
- Carol Davila University of Medicine and Pharmacy (RO)
- Singapore General Hospital (SG)
- Aarhus University Hospital (DK)
- Aga Khan University (PK)
- British Liver Trust (GB)
- Princess Alexandra Hospital (AU)
- Kuwait University (KW)
- Hlabisa Hospital (ZA)
- Catholic University of Korea (KR)
- National Academy of Medical Sciences (NP)
- National Hospital Organization Takasaki General Medical Center (JP)
- Baylor College of Medicine (US)
- National Taiwan University Hospital (TW)
- Kurume University (JP)
- Jordan University of Science and Technology (JO)
- Yonsei University (KR)
- Université d'Abomey-Calavi (BJ)
- Maastricht University Medical Centre (NL)
- The University of Tokyo (JP)
- Institut Pasteur de Bangui (CF)
- Denver Public Library (US)
- Hôpital La Rabta (TN)
- University Hospital of Bern (CH)
- Columbia University (US)
- Drexel University (US)
- Wilton Park (GB)
- Boston University (US)
- University of Tehran (IR)
- Bangladesh Medical University (BD)
- University of Bologna (IT)
- Centro Hospitalar Lisboa Norte (PT)
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
- University Hospital St. Ivan Rilski (BG)
- University of Kinshasa (CD)
- Favaloro Foundation (AR)
- Yokohama City University (JP)
- Universidad Autónoma de Nuevo León (MX)
- Ss. Cyril and Methodius University in Skopje (MK)
- St. James's Hospital (IE)
- Ljubljana University Medical Centre (SI)
- Guy's Hospital (GB)
- University of the Philippines Manila (PH)
- Lagos State University (NG)
- National and Kapodistrian University of Athens (GR)
- University Health Network (CA)
- Universidade Nova de Lisboa (PT)
- University of Palermo (IT)
- NYU Langone Health (US)
- World Obesity Federation (GB)
- University of British Columbia (CA)
- Center for Disease Analysis (US)
- Alfred Health (AU)
- Düsseldorf University Hospital (DE)
- University of Leeds (GB)
- Tartu University Hospital (EE)
- Kyrgyz State Medical Academy (KG)
- Saint Joseph University (LB)
- McGill University Health Centre (CA)
- Yotsuya Medical Cube (JP)
- Baker Heart and Diabetes Institute (AU)
- King's College London (GB)
- Tel Aviv University (IL)
- Children's Memorial Health Institute (PL)
- Hospital Universitario de La Princesa (ES)
- University of Cape Town (ZA)
- Arabian Gulf University (BH)
- Universidad San Francisco de Quito (EC)
- University of Calgary (CA)
- Charité – Universitätsmedizin Berlin (DE)
- Weill Cornell Medical College in Qatar (QA)
- Hospital Selayang (MY)
- University of Michigan (US)
- University of Southern Denmark (DK)
- University of Malawi (MW)
- Riga East University Hospital (LV)
- University of Puerto Rico, Medical Sciences Campus (PR)
- Medical University of Vienna (AT)
- Chulalongkorn University (TH)
- Nicolae Testemițanu State University of Medicine and Pharmacy (MD)
- Vilnius University Hospital Santariskiu Klinikos (LT)
- Haraldsplass Diakonale Sykehus (NO)
- National Liver Institute (EG)
- University of Edinburgh (GB)
- Stanford Medicine (US)
- Cincinnati Children's Hospital Medical Center (US)
- National University of Singapore (SG)
- Kaohsiung Medical University (TW)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Koç University (TR)
- Corresponding author
- Lazarus, Jeffrey V.
- ORCID
- Lazarus, Jeffrey V.
- Mark, Henry E.
- Anstee, Quentin M.
- Arab, Juan Pablo
- Batterham, Rachel L.
- Castera, Laurent
- Cortez-Pinto, Helena
- Crespo, Javier
- Cusi, Kenneth
- Dirac, M. Ashworth
- Francque, Sven
- George, Jacob
- Hagström, Hannes
- Huang, Terry T.-K.
- Ismail, Mona H.
- Sarin, Shiv Kumar
- Loomba, Rohit
- Miller, Veronica
- Newsome, Philip N.
- Ninburg, Michael
- Ocama, Ponsiano
- Ratziu, Vlad
- Rinella, Mary
- Romero, Diana
- Romero-Gómez, Manuel
- Schattenberg, Jörn M.
- Tsochatzis, Emmanuel A.
- Valenti, Luca
- Wong, Vincent Wai-Sun
- Yilmaz, Yusuf
- Younossi, Zobair M.
- Åberg, Fredrik
- Adams, Leon
- Naamani, Khalid Al
- Allen, Alina M.
- Alqahtani, Saleh A.
- Alswat, Khalid
- Alvaro, Domenico
- Andrade, Raúl J.
- Arrese, Marco
- Awuku, Yaw Asante
- Baatarkhuu, Oidov
- Bakieva, Shokhista
- Basu, Rita
- Bataller, Ramon
- Bedri, Shahinaz
- Bosi, Emanuele
- Bugianesi, Elisabetta
- Burra, Patrizia
- Byrne, Christopher D.
- Carrieri, Patrizia
- Chan, Henry Lik Yuen
- Chan, Wah-Kheong
- Chang, Yoosoo
- Colombo, Massimo
- Coppell, Kirsten J.
- Corey, Kathleen
- Cryer, Donna
- Dassanayake, Anuradha
- Desalegn, Hailemichael
- Dillon, John
- Duseja, Ajay
- Ekstedt, Mattias
- Elsanousi, Osama M.
- Esmat, Gamal
- Fan, Jian-Gao
- Flisiak, Robert
- Fouad, Yasser
- Fuchs, Michael
- Gani, Rino A.
- Gerber, Lynn
- Gheorghe, Liana
- Goh, George Boon-Bee
- Grønbæk, Henning
- Hamid, Saeed
- Hickman, Ingrid J.
- Hocking, Samantha L.
- Jamal, Mohammad H.
- Jepsen, Peter
- Song, Myeong Jun
- Kakizaki, Satoru
- Kanwal, Fasiha
- Kao, Jia-Horng
- Kaplan, Lee
- Kawaguchi, Takumi
- Khader, Yousef
- Kim, Seung Up
- Kodjoh, Nicolas
- Koek, Ger
- Koike, Kazuhiko
- Komas, Narcisse Patrice
- Korenjak, Marko
- Kugelmas, Marcelo
- Labidi, Asma
- Lange, Naomi F.
- Lavine, Joel E.
- Lazo, Mariana
- Lee, Nancy
- Lesmana, Cosmas Rinaldi A.
- Liu, Chun-Jen
- Long, Michelle T.
- Malekzadeh, Reza
- Mahtab, Mamun Al
- Marchesini, Giulio
- Marinho, Rui
- Vázquez, Sophia E. Martínez
- Nlombi, Charles Mbendi
- Musso, Carla
- Nakajima, Atsushi
- Norris, Suzanne
- Oben, Jude
- Ong, Janus P.
- Onyekwere, Charles
- Papatheodoridis, George
- Paruk, Imran
- Patel, Keyur
- Macedo, M. Paula
- Figueroa, Marlene Pérez
- Hofmann, Wolf Peter
- Petta, Salvatore
- Puri, Puneet
- Pan, Calvin Q.
- Ralston, Johanna
- Ramji, Alnoor
- Razavi, Homie
- Roberts, Stuart
- Roden, Michael
- Rowe, Ian A.
- Sadirova, Shakhlo
- Sebastiani, Giada
- Seki, Yosuke
- Shaw, Jonathan E.
- Sheron, Nick
- Shibolet, Oren
- Silva, Marcelo
- Socha, Piotr
- Soriano, Joan
- Spearman, C. Wendy
- Sridharan, Kannan
- Sheriff, Dhastagir Sultan
- Sung, Ki-Chul
- Swain, Mark
- Tacke, Frank
- Taheri, Shahrad
- Tan, Soek-Siam
- Tapper, Elliot B.
- Thiele, Maja
- Shawa, Isaac Thom
- Tolmane, Ieva
- Torres, Esther A.
- Trauner, Michael
- Treeprasertsuk, Sombat
- Turcanu, Adela
- Valantinas, Jonas
- Vesterhus, Mette
- Waked, Imam
- Wild, Sarah H.
- Wong, Robert J.
- Xanthakos, Stavra
- Yu, Ming-Lung
- Zheng, Kenneth I.
- Zheng, Ming-Hua
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2021-10-27
- Volume
- 19
- Issue
- 1
- Pages
- 60-78
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W3208129759
- Cited by
- 757
- References
- 193
- Citations by year
- 2026: 100 · 2025: 156 · 2024: 163 · 2023: 201 · 2022: 127 · 2021: 9
- FWCI
- 19.36
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, other-oa)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-nd)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Dspace Repository (Marmara Üniversitesi) (submittedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Falk Foundation
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- Celgene
- City University of New York
- Medpace
- Regeneron Pharmaceuticals
- European Federation of Pharmaceutical Industries and Associations
- Arrowhead Pharmaceuticals
- Medicines Company
- Galecto
- Intercept Pharmaceuticals
- NGM Biopharmaceuticals
- Coherus Biosciences
- National Institute for Health and Care Research (RP-2015-06-005)
- Rosetrees Trust
- Novo Nordisk
- Astellas Pharma
- Shionogi
- European Association for the Study of the Liver
- Novo Nordisk Fonden (NNF18OC0054612)
- Servier
- Julius Clinical
- Genentech
- Allergan
- Novartis Pharma
- Takeda Pharmaceuticals International
- Sanofi-Aventis Deutschland
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- non-alcoholic fatty liver disease, public health policy, global health agenda, metabolic syndrome, non-communicable diseases, obesity, health system response, Delphi consensus
- MeSH terms
- Humans, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.